California Nanotechnologies Corp.
CNO.V · TSXV
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.94 | 0.13 | -0.65 | -0.04 |
| FCF Yield | 3.96% | 0.89% | 19.96% | 2.28% |
| EV / EBITDA | 27.18 | 13.92 | 13.83 | 12.95 |
| Quality | ||||
| ROIC | -525.87% | 46.95% | 118.21% | 39.36% |
| Gross Margin | 73.77% | 69.88% | 36.87% | 37.95% |
| Cash Conversion Ratio | -18.47 | 0.27 | 6.84 | 0.22 |
| Growth | ||||
| Revenue 3-Year CAGR | 50.78% | 35.04% | 19.65% | 7.15% |
| Free Cash Flow Growth | 785.73% | -85.11% | 1,234.15% | 36.42% |
| Safety | ||||
| Net Debt / EBITDA | 1.39 | 0.49 | 4.87 | 6.63 |
| Interest Coverage | 7.21 | 5.99 | 2.23 | 2.03 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 1,267,515.26 |
| Cash Conversion Cycle | -108.41 | -48.51 | -37.48 | 12.62 |